MassMutual Private Wealth & Trust’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45
Closed -$9.55K 2131
2023
Q3
$9.55K Buy
45
+24
+114% +$4.79K ﹤0.01% 1025
2023
Q2
$4.04K Buy
21
+4
+24% +$795 ﹤0.01% 1274
2023
Q1
$3.44K Buy
17
+10
+143% +$1.6K ﹤0.01% 1249
2022
Q4
$1K Sell
7
-3
-30% -$387 ﹤0.01% 1611
2022
Q3
$1K Sell
10
-5
-33% -$815 ﹤0.01% 1593
2022
Q2
$3K Buy
+15
New +$2.16K ﹤0.01% 1097
2022
Q1
Sell
-8
Closed -$1K 1672
2021
Q4
$1K Sell
8
-6
-43% -$1K ﹤0.01% 1355
2021
Q3
$2K Hold
14
﹤0.01% 1105
2021
Q2
$2K Buy
+14
New +$2.08K ﹤0.01% 1073
2015
Q4
Sell
-25
Closed -$930 974
2015
Q3
$930 Hold
25
﹤0.01% 759
2015
Q2
$956 Buy
+25
New +$1.03K ﹤0.01% 681
2015
Q1
Sell
-25
Closed -$803 780
2014
Q4
$803 Hold
25
﹤0.01% 577
2014
Q3
$930 Hold
25
﹤0.01% 730
2014
Q2
$956 Hold
25
﹤0.01% 523
2014
Q1
$1.14K Buy
+25
New +$1.2K ﹤0.01% 556

Other funds holding SGEN

MassMutual Private Wealth & Trust's SGEN Position: Q4 2023 in Review

MassMutual Private Wealth & Trust sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 45 shares — an estimated $9.55K sold.

MassMutual Private Wealth & Trust first reported a position in SGEN in Q1 2014 and held it in 15 quarters. The position peaked at $9.55K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • MassMutual Private Wealth & Trust reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 45 Seagen Inc. Common Stock shares in Q4 2023, an estimated $9.55K.
  • MassMutual Private Wealth & Trust first reported a position in Seagen Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • MassMutual Private Wealth & Trust's Seagen Inc. Common Stock position peaked at $9.55K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2023, filed 3 Jan 2024.